Literature DB >> 9449289

Concentrations of cefpirome in cerebrospinal fluid of children with bacterial meningitis after a single intravenous dose.

I R Friedland1, E Sultan, K H Lehr, B Lenfant.   

Abstract

A single intravenous dose of cefpirome, 50 mg/kg, was administered to 15 children with bacterial meningitis 24 to 48 h after initiation of standard antibiotic and steroid therapy. Cefpirome concentrations in serum and cerebrospinal fluid were determined at selected time intervals. The mean (standard deviation) peak concentration in cerebrospinal fluid (n = 5) was 10.8 (7.8) microg/ml. Drug concentrations in cerebrospinal fluid above the MIC for Streptococcus pneumoniae at which 90% of the isolates were inhibited were found 2, 4, and 8 h after the dose of cefpirome was given. The penetration of cefpirome into cerebrospinal fluid compares favorably with that of other extended-spectrum cephalosporins and suggests that this agent would be useful in the therapy of childhood meningitis, including cases caused by drug-resistant S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449289      PMCID: PMC105484     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis.

Authors:  M Wolff; P Chavanet; A Kazmierczak; A Pechinot; C Dematons; H Portier; B Lenfant
Journal:  J Antimicrob Chemother       Date:  1992-04       Impact factor: 5.790

2.  Rapid chromatographic determination of cefotaxime and its metabolite in biological fluids.

Authors:  R L Yost; H Derendorf
Journal:  J Chromatogr       Date:  1985-05-31

3.  Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.

Authors:  S K Spangler; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

Review 4.  Penetration of newer cephalosporins into cerebrospinal fluid.

Authors:  C E Cherubin; R H Eng; R Norrby; J Modai; G Humbert; G Overturf
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

Review 5.  The pharmacokinetics of cefpirome--rationale for a twelve-hour dosing regimen.

Authors:  W A Craig
Journal:  Scand J Infect Dis Suppl       Date:  1993

6.  The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres.

Authors:  D S Reeves; M J Bywater; H A Holt
Journal:  J Antimicrob Chemother       Date:  1993-03       Impact factor: 5.790

7.  The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.

Authors:  A F Cheng; T K Ling; A W Lam; K S Fung; R Wise
Journal:  J Antimicrob Chemother       Date:  1993-05       Impact factor: 5.790

8.  Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  M M París; S M Hickey; M I Uscher; S Shelton; K D Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

9.  Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.

Authors:  K P Klugman; I R Friedland; J S Bradley
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.

Authors:  A L Barry; S D Brown; W J Novick
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

View more
  4 in total

1.  Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.

Authors:  K Allegaert; I Scheers; E Adams; G Brajanoski; V Cossey; B J Anderson
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

Review 2.  Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid.

Authors:  I Lutsar; I R Friedland
Journal:  Clin Pharmacokinet       Date:  2000-11       Impact factor: 6.447

3.  Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid.

Authors:  Marija Djukic; Martin Munz; Fritz Sörgel; Ulrike Holzgrabe; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

Review 4.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.